ARS Pharmaceuticals, Inc 10-K for FY2022
ARS Pharmaceuticals, Inc. (SPRY)
10-K
2023-03-23
For: 2022-12-31
View Original
Added on
April 11, 2026
About this 10-K
ARS Pharmaceuticals, Inc filed this 10-K on March 23, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.32M
- down 76.1% from $5.51M a year earlier
- Net loss
- $34.68M
- compared with a net loss of $20.24M a year earlier
- Diluted EPS
- -$0.87
- compared with -$0.70 a year earlier